NDA 205057 describes TAPENTADOL HYDROCHLORIDE, which is a drug marketed by
Novitium Pharma,
Epic Pharma Llc,
Hikma, and
MSN, and is included in four NDAs. It is available from
four suppliers. Additional details are available on the
TAPENTADOL HYDROCHLORIDE profile page.
The generic ingredient in TAPENTADOL HYDROCHLORIDE is
tapentadol hydrochloride. There is one
drug master file entry for this compound. Six
suppliers are listed for this compound. Additional details are available on the
tapentadol hydrochloride profile page.